Page last updated: 2024-11-13

reactive blue 21

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

reactive blue 21: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID72941500
MeSH IDM0445673

Synonyms (21)

Synonym
levafix turquoise blue e-g
diamira turquoise blue
reactive blue 21
c.i. reactive blue 21
sumifix turquoise blue g
remasol turquoise blue b
remasol turquoise blue g
12236-86-1
unii-377m303bwg
copper(2+) 2-((4-((2-hydroxyethyl)sulfonyl)phenyl)sulfamoyl)-9,16,23-trisulfophthalocyanine-29,31-diide
377m303bwg ,
remazol turquoise blue g
reactive turquoise blue kn-g
sunzol turquoise blue g
remazol turquoise blue g 133
sumifix turquois blue g
reactive emerald blue kn-g
DTXSID10893743
Q27256648
copper;33-[[4-(2-hydroxyethylsulfonyl)phenyl]sulfamoyl]-2,11,20,29,39,40-hexaza-37,38-diazanidanonacyclo[28.6.1.13,10.112,19.121,28.04,9.013,18.022,27.031,36]tetraconta-1,3(40),4(9),5,7,10,12(39),13(18),14,16,19,21,23,25,27,29,31(36),32,34-nonadecaene-6,1
reactiveblue21

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" A significant increase in toxicity for Reactive Blue 21 was verified, caused by the increase in the bioavailability of th e cooper ion that was in the complexed form before the treatment with ozone."( A degradation and toxicity study of three textile reactive dyes by ozone.
DurĂ¡n, N; Kunz, A; Mansilla, H, 2002
)
0.58
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (17)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (29.41)29.6817
2010's11 (64.71)24.3611
2020's1 (5.88)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 28.52

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index28.52 (24.57)
Research Supply Index2.94 (2.92)
Research Growth Index4.61 (4.65)
Search Engine Demand Index30.30 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (28.52)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (5.56%)4.05%
Observational0 (0.00%)0.25%
Other17 (94.44%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]